Annual Working Capital
$323.50 K
-$11.12 M-97.17%
December 31, 2023
Summary
- As of February 7, 2025, EPRX annual working capital is $323.50 thousand, with the most recent change of -$11.12 million (-97.17%) on December 31, 2023.
- During the last 3 years, EPRX annual working capital has risen by +$17.11 million (+101.93%).
- EPRX annual working capital is now -98.54% below its all-time high of $22.22 million, reached on December 1, 2021.
Performance
EPRX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$7.52 M
-$5.41 M-41.83%
September 1, 2024
Summary
- As of February 7, 2025, EPRX quarterly working capital is $7.52 million, with the most recent change of -$5.41 million (-41.83%) on September 1, 2024.
- Over the past year, EPRX quarterly working capital has dropped by -$5.41 million (-41.83%).
- EPRX quarterly working capital is now -74.14% below its all-time high of $29.07 million, reached on June 1, 2021.
Performance
EPRX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
EPRX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -97.2% | -41.8% |
| 3 y3 years | +101.9% | -66.2% |
| 5 y5 years | +103.7% | - |
EPRX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -98.5% | at low | -70.5% | +1651.5% |
| 5 y | 5-year | -98.5% | +101.9% | -74.1% | +144.8% |
| alltime | all time | -98.5% | +101.9% | -74.1% | +144.8% |
Eupraxia Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.52 M(-41.8%) |
| Jun 2024 | - | $12.92 M(-26.9%) |
| Mar 2024 | - | $17.69 M(+4020.8%) |
| Dec 2023 | $323.50 K(-97.2%) | $429.20 K(-96.0%) |
| Sep 2023 | - | $10.66 M(+175.3%) |
| Jun 2023 | - | $3.87 M(-75.1%) |
| Dec 2022 | $11.44 M | - |
| Dec 2022 | - | $15.53 M(-25.6%) |
| Sep 2022 | - | $20.86 M(-18.1%) |
| Jun 2022 | - | $25.46 M(+25.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $20.33 M(-8.5%) |
| Dec 2021 | $22.22 M(-232.4%) | $22.22 M(-9.7%) |
| Sep 2021 | - | $24.61 M(-15.3%) |
| Jun 2021 | - | $29.07 M(+49.1%) |
| Mar 2021 | - | $19.49 M(-216.1%) |
| Dec 2020 | -$16.79 M(+21.6%) | -$16.79 M(+4.4%) |
| Sep 2020 | - | -$16.08 M(+16.5%) |
| Dec 2019 | -$13.80 M(+58.4%) | -$13.80 M |
| Dec 2018 | -$8.72 M(-333.6%) | - |
| Dec 2017 | $3.73 M | - |
FAQ
- What is Eupraxia Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals annual working capital year-on-year change?
- What is Eupraxia Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals quarterly working capital year-on-year change?
What is Eupraxia Pharmaceuticals annual working capital?
The current annual working capital of EPRX is $323.50 K
What is the all time high annual working capital for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high annual working capital is $22.22 M
What is Eupraxia Pharmaceuticals annual working capital year-on-year change?
Over the past year, EPRX annual working capital has changed by -$11.12 M (-97.17%)
What is Eupraxia Pharmaceuticals quarterly working capital?
The current quarterly working capital of EPRX is $7.52 M
What is the all time high quarterly working capital for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high quarterly working capital is $29.07 M
What is Eupraxia Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, EPRX quarterly working capital has changed by -$5.41 M (-41.83%)